Navigation Links
From microscope to stethoscope: The MUHC's public lecture series begins its 2nd season tomorrow
Date:10/2/2007

Montreal, October 2nd, 2007 - From Microscope to Stethoscope, the distinguished public lecture series organized by the Research Institute of the McGill University Health Centre (MUHC), is embarking on its second season tomorrow.

For this opening conference, Dr. Vassilios Papadopoulos, Director of the Research Institute of the MUHC, will be sharing the hope that his current research may bring to patients suffering from Alzheimers disease. Alzheimers disease is one of the most devastating neurodegenerative pathologies, for both patients and families; unfortunately its origins are still a mystery, explains Dr Papadopoulos. His latest laboratory findings could lead to remarkable therapeutic advances and relieve the difficulties doctors currently have in terms of diagnosis and treatment.

The second lecture will be given on Monday, November 7, 2007, by Dr. Lawrence Rosenberg, a world expert in diabetes, and the third one will be by Dr. Ronald Olivenstein, MUHC Asthma Clinic Director, on Wednesday, December 3, 2007.

"Again this year, three of our most brilliant researchers invite you on a journey into a possible future, when current research has already turned into innovative treatments for patients, declared Dr. Arthur T. Porter, Director General of the MUHC. These lectures will give you a direct look at the intellectual vitality that fills our research laboratories and the enormous impact of this work on our daily lives.

The lectures will take place at the Montreal General Hospital in Livingston Hall (Rom L6-500) starting at 7:30 p.m. Admission is free and anyone interested is welcome.

The speakers will take questions from audience members during a discussion period following each lecture.


'/>"/>

Contact: Isabelle Kling
isabelle.kling@muhc.mcgill.ca
514-934-1934
McGill University Health Centre
Source:Eurekalert

Page: 1

Related medicine news :

1. Controversial deal on public access of the human genome map
2. Defibrillators In Public Places Will Help Cardiac Patients
3. WHO To Support Public Health Threats
4. Public Defibrillators Found To Improve Survival Rate
5. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
6. WHO Steps Up To Create A Public Awareness About The Consequences Of Exposure To Radon
7. Disaster Planning Guide From Harvard Health Publications
8. India to maintain Public domain Registry database of clinical trials conducted in India.
9. Smoking Ban Believed To Enjoy Widespread Public Acceptance In Scotland
10. Evidences that Better Health Care Facility is Offered By Public Hospitals.
11. UK public misled over downgrading cannabis: Govt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, ... ... today, featuring an inspirational interview of two ostomy patients, standing as living proof ... million people suffer from digestive diseases and issues that spike around the holidays. ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet ... in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition ... lives. “We are prolonging life 6 years in the last 3 decades,” says ...
(Date:12/2/2016)... ... 02, 2016 , ... Universal Medical Systems, Inc. (UMS) the ... company to offer robotic imaging to veterinary medicine is sponsoring the appearance of ... the American Association of Equine Practitioners 62nd Annual Convention from December 4-6, 2016 ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Yisrayl Hawkins, at ... into how this current generation fits into Bible Prophecy. Yisrayl says this generation, known ... pointing to this conclusion, showing how the details line up exactly with Bible Prophecy ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)...  PipelineRx, a leading medication management technology company ... of its SaaS-based telepharmacy platform, PowerGridRx™ , ... Midyear Clinical Meeting and Exhibition, December 5-7 in ... 300 hospital clients nationally, the Company is a ... dramatically improve pharmacy operations, enhance patient safety, and ...
(Date:12/2/2016)... 2016  Maxor National Pharmacy Services, LLC ("Maxor"), today announced ... ("PSI").  The combination of Texas -based Maxor ... PSI bring together both company,s clinical expertise and high-touch patient ... industry-leading specialty pharmacy. About Maxor ... , , ...
(Date:12/2/2016)... 2, 2016 Lianluo Smart Limited (Nasdaq: ... Company") which develops, markets and sells medical devices ... China and international markets, recently attended ... Treatment New Progress Forum, co-hosted by the Institute ... , Guangdong Provincial People,s Hospital and Cardiology ...
Breaking Medicine Technology: